News

onsemi (NASDAQ: ON) today disclosed details of a proposal submitted to the Board of Directors of Allegro MicroSystems, Inc. (“Allegro”) (NASDAQ: ALGM) to acquire the company for $35.10 per share in

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (the “Company” or “Acadia”) announced today that it has launched a private offering (the “Offering”) of $500 million in aggregate principal amount of

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Leerink

Interactive Brokers (Nasdaq: IBKR, ein automatisierter globaler elektronischer Broker, gab heute die Einführung von NSE IFSC Nifty 50 Index-Futures an der Singapore Exchange (SGX) bekannt. Diese

JetBlue Airways Corporation (Nasdaq: JBLU) will present at the J.P. Morgan Industrials Conference at 10:30 a.m. ET on Tuesday, March 11th, 2025.

A live, listen-only webcast of the call will be

SES S.A. has today published its 2024 Annual Report, following the announcement of the company’s full year financial results for the 12 months ended 31 December 2024.

Follow us on:

LinkedIn | Y

Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker, announced today the launch of NSE IFSC Nifty 50 Index Futures on the Singapore Exchange (SGX). This new addition

Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in a fireside chat at the Leerink

Novocure (NASDAQ: NVCR) announced today that management will participate in the Leerink Global Healthcare Conference on Tuesday, March 11, 2025. Christoph Brackmann, Chief Financial Officer, will

Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, today announced that Michael T. Broderick, President and Chief Executive Officer, Brian D’Ambrosia

Regulatory News:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250304140609/en/

Orange Africa and Middle East (OMEA) and Eutelsat

Interactive Brokers Group, Inc. (Nasdaq: IBKR) an automated global electronic broker, today reported its Electronic Brokerage monthly performance metrics for February.

Brokerage highlights for

Building upon Del Webb’s highly sought-after lifestyle communities for 55-plus homebuyers, PulteGroup Inc. (NYSE: PHM), one of the nation’s largest homebuilders, today introduced a new resort

SolarEdge Technologies, Inc. (“SolarEdge” or the “Company”) (Nasdaq: SEDG), a global leader in smart energy technology, announced today the appointment of Asaf Alperovitz as Chief Financial

United Bankshares, Inc. (“United”) (NASDAQ: UBSI), will be presenting at the Raymond James 46th Annual Institutional Investors Conference on Monday, March 3, 2025, at 10:25 a.m. (Eastern). Speaking

Semtech Corporation (Nasdaq: SMTC), a high-performance semiconductor, IoT systems and cloud connectivity service provider, today provided details on its scheduled participation at the Morgan

SES announced today a multi-year extension of its agreement with ProSiebenSat.1. Under the agreement, ProSiebenSat.1 will continue to distribute its programmes in Germany and Austria using SES’s

Semtech Corporation (Nasdaq: SMTC), a high-performance semiconductor, IoT systems and cloud connectivity service provider, announced plans to release the financial results of its fourth quarter of

Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company”) announced today that its Board of Directors has declared its second quarter dividend of $0.45 per

Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2024.

Fourth Quarter 2024

NICE (Nasdaq: NICE) today revealed a surge in the number of customer service interactions leveraging AI and automation. In 2024 alone, NICE managed the equivalent of 123,560 years of knowledge

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today reported financial results for the